ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

SCLP Scancell Holdings Plc

10.10
0.00 (0.00%)
31 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Scancell Holdings Plc LSE:SCLP London Ordinary Share GB00B63D3314 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 10.10 9.70 10.50 10.10 10.10 10.10 177,070 08:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 5.27M -11.94M -0.0129 -7.83 93.71M
Scancell Holdings Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker SCLP. The last closing price for Scancell was 10.10p. Over the last year, Scancell shares have traded in a share price range of 7.65p to 18.125p.

Scancell currently has 927,819,977 shares in issue. The market capitalisation of Scancell is £93.71 million. Scancell has a price to earnings ratio (PE ratio) of -7.83.

Scancell Share Discussion Threads

Showing 60876 to 60894 of 67200 messages
Chat Pages: Latest  2436  2435  2434  2433  2432  2431  2430  2429  2428  2427  2426  2425  Older
DateSubjectAuthorDiscuss
03/5/2023
13:30
What a little hero
IF only it were true
....
Money does not equate to happiness, or time well spent
Not that matters to YOU as someone who has NONE of the above
.....
I am just taking a break from being outdoors,(31 C in the sun, clear blue/fresh clean air, Bee Eaters flying /chattering overhead) trimming branches from trees grown on 'our' land... prior to cutting into logs 50/60 cm lengths to stack in the sun to dry-out for future log burner fuel.
....
IF YOU were half as CONtent/happy as me, I would STILL be twice as CONtent/happy as YOU
....
YOU think YOU know everything, when YOU really know NOTHING

the real lozan
03/5/2023
12:10
sadly lozan my money is actually invested in Scancell via OO to try and stop "Dead" patients from something called Cancer ....

you on the other hand together with "Gerald" the accomplice are doing everything possible to subvert that Goal

Sadly for you Scancell is winning the battle .....

but you will always be remembered for being that Grubby little Hermit who ran away from the real world to set up his clandestine operations knowing that the locals consistently bury there heads in the sand to any economic reality ....

and when you have no money ..... something follows ....

Yes, You have no shares

How is your health .... still no mention of "walking jo" or scrumping must be two years now

inanaco
03/5/2023
11:08
"RELIABLE" =
As per usual, HE draws attention to his EGOdriven FAILURES by mentioning an item HE knows NOTHING about, and an item ("RELIABLE") HE certainly = is NOT

Unless - Dead money,getting SPIKED,FAILED FALSE CLAIMS/LIES etc. are deemed something to be desired.

the real lozan
03/5/2023
10:34
Lozans Clock .... so reliable keeps perfect time
inanaco
03/5/2023
09:50
P7 -
Spot on
A case of the ill informed trHYPE brainwasher revealing HE is ignorant
The Boris brainwasher being brainwashed
REALITY
"Lozans Life ... the real France"
I spent yesterday 'mawn lowing' around patches of different Orchids ,,, a joy to behold....A lifestyle totally diverse from the landan mentality
The locals, of all ages here engage in peaceful protest = AGAINST the LOSS/STEALING of THEIR RIGHTS by the DICTATORS of world slave makers.
The world is at WAR for FREEDOM..Macron's own words some time ago
No one needs the ranting of UNRELIABLE ignorant trHYPE merchants,,, who have already 'Given in'

the real lozan
03/5/2023
09:26
Morning "Gerald"
inanaco
03/5/2023
08:38
telegraph

sadly ..... when you look out from Lozan Towers .... the grass today maybe green

but by the summer its NOT ........ 40c plus

suitable only for reptiles ...

inanaco
03/5/2023
08:35
The figures on France’s debt levels are alarming.

Total government debt has risen to 112pc of GDP, in contrast to around 66pc in Germany and 100pc in the UK. And it's rising with every year that passes.

Its government debt has surpassed Italy, in absolute terms, if not as a percentage of GDP, and it is now the third most indebted country in the world after the United States and Japan.

All that debt is mostly owed to the rest of the world.

Indeed, according to figures from the Banque de France from 2021, France by itself accounts for 8.1pc of global debt liabilities, second only to the US, and almost twice the level of Japan. And much of the borrowing is used to support a nation where government expenditure as a proportion of GDP hit 59pc in 2021.

The higher this figure rises, the more it will crush the life out of private enterprise.

inanaco
03/5/2023
08:33
Lozans Life ... the real France

Labour day strikes

The trouble is, this may not be the worst of Macron's challenges. Last week, the ratings agency Fitch downgraded France’s debt, the first major de-rating of a developed economy in years.

And that is just the start. France is now caught in a doom-loop, where even perfectly sensible reforms trigger a wave of protests, forcing yet more downgrades as the impossibility of change becomes clear, which increases the cost of all the money the state has to keep borrowing.

This could end in a full-blown sovereign debt crisis, with Paris at the centre of the storm.

inanaco
03/5/2023
08:22
Bermudashorts

GlycotimeToday 08:19
Interesting article below from Ben Schumann, Imperial College/Francis Crick which gives some background and context to the field of glycobiology . Some quotes from the article, followed by one from Scancell-

'perhaps no other field is as understated despite such a heavy clinical impact'

' Why is biomedicine still largely turning a blind eye to glycobiology? In my opinion – because they are difficult to deal with'

'glycotime” is rapidly gaining momentum in therapy and diagnosis'

'We (Scancell) remain one of only a few companies worldwide that has the capability to produce high affinity, humanised anti-glycan antibodies'

marcusl2
03/5/2023
08:22
I think they are waiting for MHRA clearance for iScib-1. Hopefully soon.
marcusl2
02/5/2023
14:12
Any ideas on when ISCIB will be entering trials?
octopus100
02/5/2023
13:11
IF -
At 15p to sell,EVEN IF "some big Pharma somewhere would want to do a partnership."
WHAT price would "some big Pharma somewhere would want to do a partnership." OFFER ???

the real lozan
02/5/2023
13:05
Inane, you're amongst the 2%, I assume you are correct and the 98% are wrong.
panama7
02/5/2023
13:03
TF, only a 2% take up of the spring booster says it all really. By the criteria on here and the other channel that means the 98% are anti-vaxxers. One might deduce that no one will be remotely interested in Covidity which will upset the happy clappers who believe that some big Pharma somewhere would want to do a partnership.
panama7
02/5/2023
10:05
Thanks Super.
torquayfan
02/5/2023
10:03
tf - not, I don't think, the NHS. Your local trust?
supernumerary
02/5/2023
09:02
I wonder if Pfizer`s $43 B acquisition of Seagen will delay an Avidimab deal if one is in the works ?
marcusl2
02/5/2023
08:50
Promising activity in CD40 based preclinical models

CD40 (cluster of differentiation 40) agonists are a promising area in immunooncology as they increase the number and quality of tumour-infiltrating T cells.
Theoretically they should be highly effective as a monotherapy or to reverse
resistance to checkpoint-blocking antibodies. However, preclinical potency has
not yet been replicated in the clinical setting and none of these mAbs have
advanced beyond early trial phases. One of the challenges encountered was
insufficient immune activation, which resulted in antitumor efficacy only
becoming apparent at toxic doses.



SEA-CD40 (Seagen) is in Phase II trials for advanced solid tumours. AvidiMab was
used in the Fc region (Exhibit 5) in an IgG1 format, with key residues from murine
IgG3 transferred into the human SEA-CD40 IgG1 Fc region. The results for iSEACD40 showed higher Fc-Fc self-association, slower off-rate and improved binding
to CD40, and better functional affinity than original SEA-CD40. These findings of
better performance were also seen in other immune models that rely on clustering
and/or increased residence time for activity. Preclinical work continues to
highlight the versatility and broad applicability of the AvidiMab platform, with
sizable improvements seen across many applications.

marcusl2
Chat Pages: Latest  2436  2435  2434  2433  2432  2431  2430  2429  2428  2427  2426  2425  Older

Your Recent History

Delayed Upgrade Clock